Literature DB >> 16930356

EFNS guidelines on the diagnosis and management of orthostatic hypotension.

H Lahrmann1, P Cortelli, M Hilz, C J Mathias, W Struhal, M Tassinari.   

Abstract

Orthostatic (postural) hypotension (OH) is a common, yet under diagnosed disorder. It may contribute to disability and even death. It can be the initial sign, and lead to incapacitating symptoms in primary and secondary autonomic disorders. These range from visual disturbances and dizziness to loss of consciousness (syncope) after postural change. Evidence based guidelines for the diagnostic workup and the therapeutic management (non-pharmacological and pharmacological) are provided based on the EFNS guidance regulations. The final literature research was performed in March 2005. For diagnosis of OH, a structured history taking and measurement of blood pressure (BP) and heart rate in supine and upright position are necessary. OH is defined as fall in systolic BP below 20 mmHg and diastolic BP below 10 mmHg of baseline within 3 min in upright position. Passive head-up tilt testing is recommended if the active standing test is negative, especially if the history is suggestive of OH, or in patients with motor impairment. The management initially consists of education, advice and training on various factors that influence blood pressure. Increased water and salt ingestion effectively improves OH. Physical measures include leg crossing, squatting, elastic abdominal binders and stockings, and careful exercise. Fludrocortisone is a valuable starter drug. Second line drugs include sympathomimetics, such as midodrine, ephedrine, or dihydroxyphenylserine. Supine hypertension has to be considered.

Entities:  

Mesh:

Year:  2006        PMID: 16930356     DOI: 10.1111/j.1468-1331.2006.01512.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  79 in total

Review 1.  Current concepts in orthostatic hypotension management.

Authors:  Amy C Arnold; Cyndya Shibao
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

Review 2.  Management of neurogenic orthostatic hypotension in patients with autonomic failure.

Authors:  Christoph Schroeder; Jens Jordan; Horacio Kaufmann
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

3.  Early discontinuation of treatment in patients with orthostatic hypotension.

Authors:  C Shibao; C G Grijalva; L A Lipsitz; I Biaggioni; M R Griffin
Journal:  Auton Neurosci       Date:  2013-08-20       Impact factor: 3.145

4.  Orthostatic hypotension among elderly patients in Italian internal medicine wards: an observational study.

Authors:  Luca Pasina; Monica Casati; Laura Cortesi; Mauro Tettamanti; Ramona Pellegrini; Ivan Oppedisano; Natale Dugnani; Androula Marinou; Gian Galeazzo Riario Sforza; Antonio Brucato
Journal:  Intern Emerg Med       Date:  2019-08-19       Impact factor: 3.397

Review 5.  L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience.

Authors:  Christopher J Mathias
Journal:  Clin Auton Res       Date:  2008-03-27       Impact factor: 4.435

6.  Disappearance of orthostatic hypotension after pacemaker implantation in a patient with a long PR interval.

Authors:  Elia De Maria; Pier Luigi Fontana; Stefano Cappelli
Journal:  Indian Heart J       Date:  2012-12-26

7.  Application of the Sit-Up Test for orthostatic hypotension in individuals with stroke.

Authors:  Ada Tang; Janice J Eng; Andrei Krassioukov
Journal:  Auton Neurosci       Date:  2012-02-29       Impact factor: 3.145

Review 8.  Clinical Relevance of Orthostatic Hypotension in Neurodegenerative Disease.

Authors:  Katherine E McDonell; Cyndya A Shibao; Daniel O Claassen
Journal:  Curr Neurol Neurosci Rep       Date:  2015-12       Impact factor: 5.081

Review 9.  Parkinson disease: an update.

Authors:  Steven J Frucht
Journal:  Neurologist       Date:  2004-07       Impact factor: 1.398

10.  Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project).

Authors:  Artur Fedorowski; Lars Stavenow; Bo Hedblad; Göran Berglund; Peter M Nilsson; Olle Melander
Journal:  Eur Heart J       Date:  2009-08-20       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.